Pacific Channel releases its internal analysis of LCT 13/05/2019, page-6

Very good analogy , a stronger strategic description of the commercial opportunity is required and within a given time frame.

LCT have been reactive to results , plenty of Highly Qualified Scientists on board but the business of LCT seems to be wanting.

Opportunity here as there always has been ,, if LCT can deliver positive results and they gain regulatory permission to continue with commercial testing, The Company still have to outline a business model , (what is the Price Point for Treatment? will it be in New Zealand? How many Treatments could be carried out per Quarter, ) would make a great licensing model with LCT controlling the NTCELL manufacturing.
Dubai would make a brilliant hub , plenty of flights and infrastructure? Obviously a USA based Private Hospital ,possibly a Swedish European Clinic?

Best of Luck